Evidence map›Paper›PMID 35999470›Full record

ArticleIntensive care medicine2022

New drugs for acute kidney injury.

Peter Pickkers, Patrick T Murray, Marlies Ostermann

Open access · hybridAbstract read
In one paragraph

Article in Intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Rewiring the mitochondrial NADMaterials today. Bio · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. RNA Therapies in Cardio-Kidney-Metabolic Syndrome: Advancing Disease Management.Journal of cardiovascular translational research · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Acute kidney injury in patients with burns.Nature reviews. Nephrology · 2024
    Review
  20. Designing acute kidney injury clinical trials.Nature reviews. Nephrology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Peter PickkersDepartment Intensive Care, Radboud University Medical Center, Nijmegen, The Netherlands. peter.pickkers@radboudumc.nl.ORCID http://orcid.org/0000-0002-1104-4303
Patrick T MurraySchool of Medicine, University College Dublin, Dublin, Ireland.
Marlies OstermannDepartment of Critical Care, King's College London, Guy's and St Thomas' Hospital, London, UK.
Radboud University Nijmegen · NLSt Thomas' Hospital · GBUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryAngiotensin-Converting Enzyme InhibitorsHumansKidneyAngiotensin-Converting Enzyme Inhibitors

Identifiers

PMID35999470
PMCPMC9705447
OpenAlexW4292801151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.